The amplatzer [corrected] septal occluder as a standard for therapy of secundum-type [corrected] atrial septal defect

William D Hales1, Satinder K Sandhu, Edmund Kenneth Kerut

  • 1Metairie Park Country Day School, Metairie, Louisiana, USA.

Insights

Atrial septal defect (ASD) is a common congenital heart issue. Percutaneous device closure offers a minimally invasive option for secundum ASDs, with successful outcomes in pediatric and adult patients.

Area of Science:

  • Cardiology
  • Pediatric Cardiology
  • Congenital Heart Disease

Background:

  • Atrial septal defect (ASD) represents 5-10% of congenital heart malformations.
  • Untreated ASD can lead to serious complications like heart failure, pulmonary hypertension, and stroke.
  • Diagnostic imaging includes echocardiography, with transesophageal echocardiography sometimes needed for adults.

Purpose of the Study:

  • To outline ASD types and diagnostic methods.
  • To present outcomes of percutaneous closure for secundum ASDs.
  • To evaluate the efficacy of device closure in a mixed pediatric and adult cohort.

Main Methods:

  • Review of ASD classifications and diagnostic approaches.
  • Description of percutaneous device closure technique for secundum ASDs.
  • Analysis of clinical data from 74 patients undergoing percutaneous closure.

Main Results:

  • Percutaneous closure is a viable alternative to surgery for secundum ASDs.
  • Successful closure was achieved in the presented cohort of 74 children and adults.
  • Minimally invasive closure demonstrated positive outcomes in diverse age groups.

Conclusions:

  • Secundum ASDs can be effectively managed with percutaneous device closure.
  • This technique provides a safe and efficient treatment option for both pediatric and adult patients.
  • Percutaneous closure is a significant advancement in the management of congenital heart defects.